Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England

Lancet

Volumn 357, Issue 9267, 2001, Pages 1490-1493

  Sasieni, Peter ^a   Adams, Joanna ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; AGE; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; HUMAN; PAPILLOMA VIRUS; PREDICTION; PRIORITY JOURNAL; UNITED KINGDOM; UTERINE CERVIX; UTERINE CERVIX CARCINOMA;

EID: 0035849309     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04646-8     Document Type: Article

References (15)

1. Parkin DM, Nguyen-Dinh X, Day NE. The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol 1985; 92: 150-57.
2. Bergstrom R, Sparen P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. BrJ Cancer 1999; 81: 159-66.
3. Stockton D, Cooper P, Lonsdale RN. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia. J Med Screen 1997; 4: 40-43.
4. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Parkin DM. International trends in the incidence of cervical cancer: I, adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998; 75: 536-45.
5. Sasieni PD, Adams J. Analysis of cervical cancer mortality and incidence data from England and Wales: evidence of a beneficial effect of screening. J R Statist Soc A 2000; 163: 191-209.
6. Office for National Statistics. Cancer statistics: registrations 1993, series MB1 number 26. London: Stationery Office, 1999.
7. McCullagh P, Nelder JA. Generalized linear models, 2nd edn. London: Chapman and Hall, 1989: 324-28.
8. Sasieni P, Adams J. Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with age period cohort model. BMJ 1999; 318: 1244-45.
9. Sasieni PD, Adams J. Standardized lifetime risk. Am J Epidemiol 1999; 149: 869-75.
10. Office for National Statistics. Cervical Screening Programme, England 1999-2000. Statistical bulletin 2000/30. London: Department of Health, 2000.
11. Beral V. Cancer of the cervix: a sexually transmitted infection? Lancet 1974; 1: 1037-40.
12. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses, vol 64. Lyons: IARC, 1995.
13. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer - a worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
14. Ursin G, Peters RK, Henderson BE, d'Ablaing G, Monroe KR, Pike MC. Oral-contraceptive use and adenocarcinoma of cervix. Lancet 1994; 344: 1390-94.
15. Lacey JV, Brinton LA, Abbas FM, et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomark Prev 1999; 8: 1079-85.